India’s first pneumococcal conjugate vaccine
Health Minister inaugurates India’s first pneumococcal conjugate vaccine

Health Minister Dr Harsh Vardhan inaugurated India’s first pneumococcal conjugate vaccine, PCV. The vaccine named Pneumosil has been developed by the Serum Institute of India Private Limited, SIIPL in collaboration with partners like the Bill and Melinda Gates Foundation. Recognizing SIIPL as the world’s largest manufacturer of vaccines by number of doses and its contribution to India’s economy, Dr. Harsh Vardhan remarked that Serum Institute’s Vaccines are used in 170 countries and every third child in the world is immunized with the manufacturer’s vaccine. He reminded the audience that SIIPL developed and got license of first indigenous Pneumococcal Conjugate Vaccine from Government of India during COVID-19 pandemic lock-down in line with Prime Minister Narendra Modi’s vision of Atmanirbhar Bharat.


Surbhi Saxena edits the daily Current Affairs News.
The author is qualified member of The Institute of Company Secretaries of India (ICSI).